NCT00877526 - A Survey to Evaluate Diabetes Management, Control, Chronic Complications, Psychosocial Aspects of Diabetic Subjects in Malaysia | Crick | Crick

A Survey to Evaluate Diabetes Management, Control, Chronic Complications, Psychosocial Aspects of Diabetic Subjects in Malaysia

N/ACompletedNCT00877526

Novo Nordisk A/S1,670 enrolled

Overview

This study is conducted in Asia. The aim of this observational study is to evaluate current status of diabetes management, control, and complications in diabetic subjects in Asia.

Study Type

OBSERVATIONAL

Enrollment

1,670

Conditions

Diabetes Diabetes Mellitus, Type 1 Diabetes Mellitus, Type 2

Interventions

No treatment givenOTHER

Subject will only fill out a questionaire when entering the observational study.

Eligibility

Sex: ALL

Medical Language ↔ Plain English

Inclusion Criteria: * Diabetic patients registered in the particular centre for more than 12 months. * Patients should have visited the centre at least once in the last 3-6 months apart from the initial visit. * Patients willing to sign informed consent form. Exclusion Criteria: * Repetition of any patient as patients should not be included twice for any reason. * Unwilling to participate or unable to comply with protocol requirements.

Locations (1)

Novo Nordisk Investigational Site

Selangor Darul Ehsan, Malaysia

Outcomes

Primary Outcomes

Mean age of onset of type 1 and type 2 diabetes mellitus, respectively

Time frame: at baseline visit/study start

Mean duration of treatment of type 2 Diabetes mellitus

Time frame: at baseline visit/study start

Percentage of patients on insulin and Oral Anti-Diabetics Drugs (OADs) theraphy, respectively

Time frame: at baseline visit/study start

Mean duration of diabetes in type 1 and type 2 diabetic patients respectively

Time frame: at baseline visit/study start

Mean FPG (Fasting plasma glucose), PPG (Post prandial glucose) and HbA1c of diabetic patients

Time frame: at baseline visit/study start

Percentage of diabetic patients with HbA1c target below 7.0% and below 6.5%, respectively

Time frame: at baseline visit/study start

Percentage of diabetic patients having dyslipidemia and hypertension, cardiovascular complications, peripheral vascular disease, diabetic nephropathy and diabetic eye complications, respectively

Time frame: at baseline visit/study start

Secondary Outcomes

Patients' perception will be analysed through patient questionnaire measuring: Psychological well-being, Quality of Life and patients' compliant to treatmen

Time frame: at baseline visit/study start

Physician perception of diabetes and its management will be analysed through physician questionnaire measuring awareness about: HbA1c test and its goal, anti-diabetic treatment, barriers towards optimum diabetes control

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.